FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort

PDF) Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

Flow chart of patient selection. BASDAI, Bath Ankylosing Spondylitis

PDF) OP0078 MAPPING FROM THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE ( ASDAS) TO EQ5D IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies

Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil, Advances in Rheumatology

Disease Control Data, Ankylosing Spondylitis

POS0241 VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (ASDAS-QCRP) IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS (AXSPA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY

Inflammatory markers, disease activity, functional index and quality of

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Victoria NAVARRO-COMPÁN, Leiden University Medical Centre, Leiden, LUMC, Department of Rheumatology

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies

ASDAS calculator - ASAS